سعر اوكتانيت 500 وحدة دولية/مل فيال 10 مل 2026

Octapharma Octanate human coagulation factor VIII, 500 IU/ml, vial 10 ml.

• Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency)AEMPS CIMA
• May be used in the management of acquired factor VIII deficiencyAEMPS CIMA
• Treatment and prophylaxis of bleeding in haemophilia A (congenital factor VIII deficiency)electronic medicines compendium (emc) / MHRA

• Very rare hypersensitivity/allergic reactions (may progress to severe anaphylaxis including shock); factor VIII inhibition (uncommon in previously treated patients; very common in previously untreated patients across FVIII products); very rare fever.International label, equivalent formulation · AEMPS CIMA

• Hypersensitivity to the active substance or to any of the excipients.International label, equivalent formulation · AEMPS CIMA
• Hypersensitivity to the active substance or to any of the excipients.International label, equivalent formulation · electronic medicines compendium (emc) / MHRA

• Allergic-type hypersensitivity reactions may occur; stop administration if symptoms appear (urticaria, chest tightness, dyspnoea, hypotension, anaphylaxis) and treat shock per standards.International label, equivalent formulation · AEMPS CIMA
• Neutralising antibodies (inhibitors) to factor VIII are a known complication; monitor clinically and with Bethesda assay. High-titre inhibitors may render FVIII ineffective — manage in a haemophilia centre.International label, equivalent formulation · AEMPS CIMA
• Despite viral-safety manufacturing steps, transmission of infectious agents from human plasma products cannot be totally excluded; appropriate hepatitis A and B vaccination is recommended for regularly treated patients.International label, equivalent formulation · AEMPS CIMA

• Other medicines (general)No interactions of human coagulation factor VIII-containing products with other medicines have been reported.AEMPS CIMA

• No animal reproduction studies with factor VIII. Because haemophilia A is rare in women, clinical experience in pregnancy and lactation is lacking; use only if clearly indicated.International label, equivalent formulation · AEMPS CIMA
• Use in lactation only if clearly indicated (same SmPC statement covering pregnancy and lactation).International label, equivalent formulation · AEMPS CIMA

• Human coagulation factor VIII: Activated factor VIII cofactor for activated factor IX, accelerating conversion of factor X to Xa, enabling clot formation (Beriate SmPC 5.1).